| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |